Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...